Research proposals on the comparative effectiveness of long-term opioid use for chronic pain, the blood clot dissolving drugs, therapies for multiple sclerosis, and strategies for treatment-resistant depression are among the studies that will be considered for funding by the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors at its next meeting. The Board will vote on funding awards for these and other proposed studies when it meets on Tuesday, July 19.
When and Where: The meeting will run from noon to 2 p.m. ET Tuesday, July 19, via teleconference and webinar. Register here to listen.
Interviews:
To schedule an interview with PCORI Executive Director Joe Selby, MD, MPH, or any of the researchers whose proposed studies are approved during the meeting, please contact Mary McNamara, PCORI’s Senior Media Relations Specialist: 202-370-9480 or mmcnamara@pcori.org.
The Patient-Centered Outcomes Research Institute (PCORI) is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make the better-informed healthcare decisions. PCORI is committed to continually seeking input from a broad range of stakeholders to guide its work. More information is available at www.pcori.org.